Sex-based differences of the tumor mutational burden and T-cell inflammation of the tumor microenvironment
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
|---|---|
| Enthalten in: |
Annals of oncology : official journal of the European Society for Medical Oncology - 30(2019), 4 vom: 01. Apr., Seite 653-655 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Conforti, F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal, Humanized |
|---|
| Anmerkungen: |
Date Completed 20.04.2020 Date Revised 29.02.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/annonc/mdz034 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM293256187 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM293256187 | ||
| 003 | DE-627 | ||
| 005 | 20240229232621.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdz034 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1311.xml |
| 035 | |a (DE-627)NLM293256187 | ||
| 035 | |a (NLM)30698647 | ||
| 035 | |a (PII)S0923-7534(19)31120-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Conforti, F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sex-based differences of the tumor mutational burden and T-cell inflammation of the tumor microenvironment |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.04.2020 | ||
| 500 | |a Date Revised 29.02.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Antineoplastic Agents, Immunological |2 NLM | |
| 650 | 7 | |a Biomarkers, Tumor |2 NLM | |
| 650 | 7 | |a pembrolizumab |2 NLM | |
| 650 | 7 | |a DPT0O3T46P |2 NLM | |
| 700 | 1 | |a Pala, L |e verfasserin |4 aut | |
| 700 | 1 | |a Bagnardi, V |e verfasserin |4 aut | |
| 700 | 1 | |a Viale, G |e verfasserin |4 aut | |
| 700 | 1 | |a De Pas, T |e verfasserin |4 aut | |
| 700 | 1 | |a Pagan, E |e verfasserin |4 aut | |
| 700 | 1 | |a Gelber, R D |e verfasserin |4 aut | |
| 700 | 1 | |a Goldhirsch, A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology : official journal of the European Society for Medical Oncology |d 1990 |g 30(2019), 4 vom: 01. Apr., Seite 653-655 |w (DE-627)NLM012606308 |x 1569-8041 |7 nnns |
| 773 | 1 | 8 | |g volume:30 |g year:2019 |g number:4 |g day:01 |g month:04 |g pages:653-655 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/annonc/mdz034 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 30 |j 2019 |e 4 |b 01 |c 04 |h 653-655 | ||